

Rusan Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.84 Cr
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 259.97 Cr
- Satisfied Charges ₹ 80.83 Cr
- Revenue Growth 0.17%
- Profit Growth -33.95%
- Ebitda -20.66%
- Net Worth 18.29%
- Total Assets 18.81%
About Rusan Pharma
Rusan Pharma Limited (RPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 15 March 1994 and has a history of 30 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Rusan Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.84 Cr.
The company currently has active open charges totaling ₹259.97 Cr. The company has closed loans amounting to ₹80.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kunal Saxena, Aakarsh Saxena, Sandeep Verma, and Two other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230MH1994PLC077069
- Company No.
077069
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Mar 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Rusan Pharma Limited offer?
Rusan Pharma Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Common Disease Medicines, Anti Smoking Drugs, Specialty Supplements, Antioxidants, Popular Category, Bone & Joint Care, Health Conditions, Smoking Cessation.
Who are the key members and board of directors at Rusan Pharma?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kunal Saxena ![]() | Managing Director | 05-Apr-2012 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sandeep Verma ![]() | Director | 20-Mar-2023 | Current |
Aakarsh Saxena ![]() | Whole-Time Director | 10-Feb-2016 | Current |
Balasaheb Patil ![]() | Whole-Time Director | 17-Oct-2012 | Current |
Navin Sexena ![]() | Director | 15-Mar-1994 | Current |
Financial Performance of Rusan Pharma.
Rusan Pharma Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.17% increase. The company also saw a substantial fall in profitability, with a 33.95% decrease in profit. The company's net worth Soared by an impressive increase of 18.29%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Rusan Pharma?
In 2023, Rusan Pharma had a promoter holding of 99.99% and a public holding of 0.01%. The company had 1 Subsidiary and 6 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Quantys Clinical Private Limited
Kunal Saxena and Navin Sexena are mutual person
- Navicare Pharma Private Limited
Kunal Saxena and Navin Sexena are mutual person
- Rusan Health Care Private Limited
Kunal Saxena, Balasaheb Patil and 1 more are mutual person
- Tuscany Holdings Private Limited
Kunal Saxena and Navin Sexena are mutual person
- Iitk Foundation For Medical Research And Technology
Sandeep Verma is a mutual person
Charges (Loans)
₹259.97 Cr
₹80.83 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 169.13 Cr
- Others : 52.50 Cr
- State Bank Of India : 38.34 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
16 Dec 2022 | Others | ₹10.00 Cr | Open |
27 Jul 2022 | Others | ₹10.00 Cr | Open |
31 Aug 2021 | Canara Bank | ₹75.00 Cr | Open |
29 Sep 2020 | Canara Bank | ₹16.50 Cr | Open |
23 May 2020 | Others | ₹16.50 Cr | Open |
How Many Employees Work at Rusan Pharma?
Rusan Pharma has a workforce of 656 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Rusan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rusan Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Rusan Pharma
Recent activity within the organization
- Annual General Meeting
Rusan Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Rusan Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge registered on 28 Jun 2016 via Charge ID 100042892 with Syndicate Bank was fully satisfied on 30 Jan 2024.
- Charges
A charge registered on 20 Jul 2020 via Charge ID 100504641 with Canara Bank was fully satisfied on 01 Jan 2024.
- Director Appointment
Sandeep Verma was appointed as a Director was appointed as a Director on 20 Mar 2023 & has been associated with this company since 1 year 11 months .
- Charges
A charge with Others of Rs. 16.00 Cr registered on 28 Dec 2015 with Charge ID 10614211 was modified on 06 Feb 2023.
Recent News, Updates & Announcement
- Rusan Pharma launches Parkinson's Disease drug.
The company said it has developed the drug, which would be available in the form of injections, pen and continuous infusion pumps, indigenously and has received approval from the Drug Controller General of India (DCGI). .
Frequently asked questions
What is the Incorporation or founding date of Rusan Pharma Limited?
Rusan Pharma Limited was incorporated on 15 Mar 1994.
What is authorized share capital and paid-up capital of Rusan Pharma Limited?
The authorized share capital of Rusan Pharma Limited is ₹ 5.00 Cr and paid-up capital is ₹ 4.84 Cr.
Who are the current board members & directors of Rusan Pharma Limited?
Currently 5 directors are associated with Rusan Pharma Limited.
- Kunal Navin Saxena
- Aakarsh Navin Saxena
- Sandeep Verma
- Balasaheb Annasaheb Patil
- Navin Satyapal Sexena
What is the registered address of Rusan Pharma Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Rusan Pharma Limited is 58-D Government Industrial Estate Charkop, Kandivali West India, Mumbai, Maharashtra, 400067.
What is the corporate identification number (CIN) and company number of Rusan Pharma Limited?
The corporate identification number (CIN) of Rusan Pharma Limited is U24230MH1994PLC077069 and the company number is 077069 as per Ministry of Corporate Affairs (MCA).
What is the official website of Rusan Pharma Limited?
The Official website of Rusan Pharma Limited is https://www.rusanpharma.com
What has been the recent revenue trend for Rusan Pharma Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Rusan Pharma Limited has risen by 0.17%.
How many employees does Rusan Pharma Limited currently have?
As Per 2022 financial reports, 656 employees are currently employed by Rusan Pharma Limited.
What change has been observed in the net worth of Rusan Pharma Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Rusan Pharma Limited has experienced an upsurge of 18.29%.
What are the total open charges for Rusan Pharma Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Rusan Pharma Limited amount to ₹ 259.97 Cr.
When was the last Balance Sheet of Rusan Pharma Limited filed with the ROC?
The most recent Balance Sheet for Rusan Pharma Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
NU
Naduvil UnnikrishnanDirectorAS
Ajay SaxenaWhole-Time DirectorRP
Ramesh PatelDirectorDD
Dilipkumar DesaiManaging Director